Studying How Sleep Habits Affect Muscle Loss and Thinking Abilities in Adults with COPD or Idiopathic Pulmonary Fibrosis

What this Trial Is About

This research aims to clarify how sleep hygiene relates to the development of sarcopenia muscle loss and cognitive dysfunction in patients with chronic obstructive pulmonary disease COPD or idiopathic pulmonary fibrosis IPF. It focuses on measuring sleep time, arousal, and sleep quality to understand their effects on disease progression and life expectancy in these patients. Sleep-related disorders like insomnia and sleep apnea are common in COPD and IPF and may contribute to daytime sleepiness, reduced daily activities, depression, and cognitive issues. The study observes patients with COPD or IPF without providing any specific treatment or intervention. Researchers will monitor participants sleep patterns, including sleep time and sleep efficiency, as well as arousal during sleep. These indicators will be used to explore their relationship with the onset of sarcopenia and mild cognitive impairment over a two-year period. The study also examines how these sleep factors relate to hospitalizations and mortality from disease exacerbations. Participants will undergo assessments at enrollment and during follow-up to measure sleep quality, muscle strength, walking speed, skeletal muscle mass, and cognitive function. Researchers will track changes in these areas and record hospitalizations and deaths related to COPD or IPF exacerbations over two years. The main outcome is the link between sleep time at enrollment and the development of sarcopenia during follow-up, with secondary outcomes including cognitive impairment and other health changes. The study includes close monitoring but does not involve experimental treatments.

Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease